Why Novo Nordisk’s Weight Loss Pill Has Taken Off
Novo Nordisk's weight loss pill is expanding the obesity treatment market as an alternative to injectable GLP-1 medications. CNBC spoke ...
Saturday, April 11, 2026
Tag: Novo Nordisk patents
What’s Stopping GLP-1s From Getting Cheaper
The push to make weight loss drugs more affordable is running into legal limits. Telehealth company Hims & Hers pulled ...
Stay updated with DeFi Daily, your trusted source for the latest news, insights, and analysis in finance and cryptocurrency. Explore breaking news, expert analysis, market data, and educational resources to navigate the world of decentralized finance.